Achieve Life Sciences (ACHV) Current Leases (2010 - 2026)
Achieve Life Sciences' (ACHV) quarterly Current Leases came in at $51000.0 in Q1 2026, down 10.53% YoY from $57000.0 in Q1 2025, and down 16.39% on a QoQ basis from $61000.0 in Q4 2025.
Achieve Life Sciences (ACHV) Current Leases (2010 - 2026) Analysis & Trends
Achieve Life Sciences (ACHV) has 17 years of Current Leases data on file, last reported at $51000.0 in Q1 2026.
- Quarterly Current Leases fell 10.53% year-over-year to $51000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $51000.0 (down 10.53% YoY) and the FY2025 annual result came in at $61000.0, up 10.91% from the prior year.
- Current Leases eased to $51000.0 in Q1 2026, from $61000.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $63000.0 in Q4 2023 to a low of $22000.0 in Q3 2024.
- A 5-year average of $51529.4 and a median of $58000.0 in 2022 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2022 — Current Leases slumped 66.67% — and 2025, when it jumped 168.18%.
- Tracing ACHV's Current Leases over 5 years: stood at $58000.0 in 2022, then grew by 8.62% to $63000.0 in 2023, then slipped by 12.7% to $55000.0 in 2024, then climbed by 10.91% to $61000.0 in 2025, then declined by 16.39% to $51000.0 in 2026.
- The last three Current Leases figures came in at $51000.0 (Q1 2026), $61000.0 (Q4 2025), and $59000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 11.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 16.75 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 21.95 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.24 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 45.93 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.27 Mn |
| 10 | Achieve Life Sciences | 330.88 Mn | 330.88 Mn | - | 36,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 36,000.00 |
| Mar 31, 2026 | 51,000.00 |
| Dec 31, 2025 | 61,000.00 |
| Sep 30, 2025 | 59,000.00 |
| Jun 30, 2025 | 58,000.00 |
| Mar 31, 2025 | 57,000.00 |
| Dec 31, 2024 | 55,000.00 |
| Sep 30, 2024 | 22,000.00 |
| Jun 30, 2024 | 37,000.00 |
| Mar 31, 2024 | 53,000.00 |
| Dec 31, 2023 | 63,000.00 |
| Sep 30, 2023 | 61,000.00 |
| Jun 30, 2023 | 60,000.00 |
| Mar 31, 2023 | 58,000.00 |
| Dec 31, 2022 | 58,000.00 |
| Sep 30, 2022 | 23,000.00 |
| Jun 30, 2022 | 41,000.00 |
| Mar 31, 2022 | 59,000.00 |
| Dec 31, 2021 | 69,000.00 |
| Sep 30, 2021 | 69,000.00 |